Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Toluwalase Awoyemi, DPhil student in Nuffield Department of Women's & Reproductive Health, is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.

Toluwalase Awoyemi talking to a group of students in Nigeria

35 young changemakers from Africa and the diaspora hailing from 24 countries made it to the list of the Africa 35.35 Awards celebrating African youth and afro-diaspora excellence.

The Africa 35.35 Awards have announced the 35 under 35 most inspiring young personalities in Africa. It is a prestigious list of 35 young personalities aged 18 to 35 who stand out in Africa and around the world.

Selected from more than 500 applicants, these young people living in Africa and in the Diaspora are credited with exceptional achievements in their communities.

We are extremely proud to say that one of the winners is Dr Toluwalase Awoyemi, a Rhodes scholar, DPhil student at the Nuffield Department of Women's Reproductive Health, University of Oxford and co-founder of The Ganglion Initiative. This social enterprise aims to improve college admission services and career counseling really early, engaging students in public high schools across Nigeria. It organizes free webinars for admission to foreign scholarships with a fairly remarkable total audience of 2,221 people in the first two editions.

The full story is available on the Nuffield Department of Women's & Reproductive Health website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.